(CMCO) Columbus McKinnon - Overview
Stock: Hoists, Conveyors, Chains, Actuators, Drives
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.59% |
| Yield on Cost 5y | 0.60% |
| Yield CAGR 5y | 3.93% |
| Payout Consistency | 54.4% |
| Payout Ratio | 16.3% |
| Risk 5d forecast | |
|---|---|
| Volatility | 48.1% |
| Relative Tail Risk | -11.1% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.23 |
| Alpha | -55.61 |
| Character TTM | |
|---|---|
| Beta | 1.554 |
| Beta Downside | 1.268 |
| Drawdowns 3y | |
|---|---|
| Max DD | 72.13% |
| CAGR/Max DD | -0.19 |
Description: CMCO Columbus McKinnon December 28, 2025
Columbus McKinnon (CMCO) designs, manufactures and markets a broad portfolio of motion-control and material-handling equipment-including manual and electric chain hoists, wire-rope hoists, high-precision conveyors, and custom-engineered lifting solutions-plus ancillary components such as alloy chains, hooks, actuators and crane kits. The company also supplies digital motion-control systems for underground mining, elevator-specific drives, and aluminum light-rail workstations.
Its end-users span a wide array of end-markets: EV production, aerospace, energy & utilities, process industries, construction & infrastructure, food & beverage, life sciences, e-commerce fulfillment, and entertainment. Distribution is split between direct sales, industrial distributors (including rigging shops and crane builders), system integrators, OEMs, and government/ EPC contracts.
Key operating metrics (FY 2023) show revenue of roughly $1.2 billion, an operating margin of ~10.5 % and a backlog of about $600 million, indicating a solid order pipeline. Growth is partially driven by secular trends-U.S. infrastructure spending (+4 % YoY) and accelerating EV-vehicle manufacturing (+12 % of CMCO’s revenue exposure)-both of which boost demand for high-capacity hoists and conveyor systems. However, sensitivity to cyclical construction activity and commodity-price volatility remains a material risk.
For a deeper, data-driven view of CMCO’s valuation dynamics, you may find ValueRay’s analytical platform worth exploring.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 3.97m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.02 > 0.02 and ΔFCF/TA -0.69 > 1.0 |
| NWC/Revenue: 21.94% < 20% (prev 23.77%; Δ -1.83% < -1%) |
| CFO/TA 0.03 > 3% & CFO 47.2m > Net Income 3.97m |
| Net Debt (431.2m) to EBITDA (85.8m): 5.02 < 3 |
| Current Ratio: 1.81 > 1.5 & < 3 |
| Outstanding Shares: last quarter (28.8m) vs 12m ago -0.10% < -2% |
| Gross Margin: 33.67% > 18% (prev 0.34%; Δ 3333 % > 0.5%) |
| Asset Turnover: 55.15% > 50% (prev 56.37%; Δ -1.22% > 0%) |
| Interest Coverage Ratio: 1.12 > 6 (EBITDA TTM 85.8m / Interest Expense TTM 33.3m) |
Altman Z'' 2.12
| A: 0.12 (Total Current Assets 480.5m - Total Current Liabilities 265.9m) / Total Assets 1.77b |
| B: 0.22 (Retained Earnings 382.8m / Total Assets 1.77b) |
| C: 0.02 (EBIT TTM 37.2m / Avg Total Assets 1.77b) |
| D: 0.46 (Book Value of Equity 390.0m / Total Liabilities 855.3m) |
| Altman-Z'' Score: 2.12 = BBB |
Beneish M -3.00
| DSRI: 1.02 (Receivables 179.3m/179.2m, Revenue 978.0m/1.00b) |
| GMI: 1.02 (GM 33.67% / 34.39%) |
| AQI: 1.05 (AQ_t 0.67 / AQ_t-1 0.64) |
| SGI: 0.98 (Revenue 978.0m / 1.00b) |
| TATA: -0.02 (NI 3.97m - CFO 47.2m) / TA 1.77b) |
| Beneish M-Score: -3.00 (Cap -4..+1) = AA |
What is the price of CMCO shares?
Over the past week, the price has changed by +7.97%, over one month by +17.38%, over three months by +46.08% and over the past year by -33.42%.
Is CMCO a buy, sell or hold?
- StrongBuy: 1
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the CMCO price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 26.8 | 17.5% |
| Analysts Target Price | 26.8 | 17.5% |
| ValueRay Target Price | 23.6 | 3.8% |
CMCO Fundamental Data Overview February 02, 2026
P/E Forward = 10.9409
P/S = 0.6192
P/B = 0.6634
P/EG = 0.464
Revenue TTM = 978.0m USD
EBIT TTM = 37.2m USD
EBITDA TTM = 85.8m USD
Long Term Debt = 408.5m USD (from longTermDebt, last quarter)
Short Term Debt = 50.8m USD (from shortTermDebt, last quarter)
Debt = 459.3m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 431.2m USD (from netDebt column, last quarter)
Enterprise Value = 1.04b USD (605.6m + Debt 459.3m - CCE 28.0m)
Interest Coverage Ratio = 1.12 (Ebit TTM 37.2m / Interest Expense TTM 33.3m)
EV/FCF = 35.31x (Enterprise Value 1.04b / FCF TTM 29.4m)
FCF Yield = 2.83% (FCF TTM 29.4m / Enterprise Value 1.04b)
FCF Margin = 3.00% (FCF TTM 29.4m / Revenue TTM 978.0m)
Net Margin = 0.41% (Net Income TTM 3.97m / Revenue TTM 978.0m)
Gross Margin = 33.67% ((Revenue TTM 978.0m - Cost of Revenue TTM 648.7m) / Revenue TTM)
Gross Margin QoQ = 34.54% (prev 32.73%)
Tobins Q-Ratio = 0.59 (Enterprise Value 1.04b / Total Assets 1.77b)
Interest Expense / Debt = 1.90% (Interest Expense 8.75m / Debt 459.3m)
Taxrate = 21.0% (US default 21%)
NOPAT = 29.4m (EBIT 37.2m * (1 - 21.00%))
Current Ratio = 1.81 (Total Current Assets 480.5m / Total Current Liabilities 265.9m)
Debt / Equity = 0.50 (Debt 459.3m / totalStockholderEquity, last quarter 914.6m)
Debt / EBITDA = 5.02 (Net Debt 431.2m / EBITDA 85.8m)
Debt / FCF = 14.69 (Net Debt 431.2m / FCF TTM 29.4m)
Total Stockholder Equity = 894.8m (last 4 quarters mean from totalStockholderEquity)
RoA = 0.22% (Net Income 3.97m / Total Assets 1.77b)
RoE = 0.44% (Net Income TTM 3.97m / Total Stockholder Equity 894.8m)
RoCE = 2.85% (EBIT 37.2m / Capital Employed (Equity 894.8m + L.T.Debt 408.5m))
RoIC = 2.15% (NOPAT 29.4m / Invested Capital 1.36b)
WACC = 7.27% (E(605.6m)/V(1.06b) * Re(11.64%) + D(459.3m)/V(1.06b) * Rd(1.90%) * (1-Tc(0.21)))
Discount Rate = 11.64% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -0.26%
[DCF Debug] Terminal Value 77.24% ; FCFF base≈34.3m ; Y1≈27.1m ; Y5≈17.9m
Fair Price DCF = N/A (negative equity: EV 383.7m - Net Debt 431.2m = -47.6m; debt exceeds intrinsic value)
EPS Correlation: -64.69 | EPS CAGR: -48.86% | SUE: -4.0 | # QB: 0
Revenue Correlation: 42.81 | Revenue CAGR: 5.17% | SUE: 2.78 | # QB: 1
EPS next Year (2027-03-31): EPS=2.59 | Chg30d=-0.196 | Revisions Net=+0 | Growth EPS=+4.3% | Growth Revenue=+3.9%